Bachrodt Amy

CIK 00020504221 companySOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0002050422

Recent Transactions

30 trades

Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-02-02−156→ 41,333 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-02-02−4,844→ 3,025 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-02-02$46.63/sh−736→ 12,965 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-02-02$46.03/sh−4,064→ 13,701 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-02-02$44.15/sh−200→ 17,765 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-02-02$10.42/sh+156→ 17,965 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-02-02$10.42/sh+4,844→ 17,809 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-01-22$10.42/sh+2,503→ 17,965 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-01-22$10.42/sh+2,497→ 15,462 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-01-22−2,503→ 7,869 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-01-22−2,497→ 486 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-01-22$45.52/sh−5,000→ 12,965 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-01-02$39.57/sh−2,595→ 12,965 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-01-02$10.42/sh+204→ 13,169 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-01-02$10.42/sh+4,796→ 17,965 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-01-02$38.70/sh−2,405→ 15,560 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-01-02−204→ 2,377 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-01-02−4,796→ 2,983 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2025-12-30$10.42/sh+2,605→ 17,965 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2025-12-30$10.42/sh+2,395→ 15,360 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2025-12-30−2,605→ 2,581 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2025-12-30−2,395→ 1 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2025-12-30$40.08/sh−5,000→ 12,965 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2025-12-29$10.42/sh+9,876→ 22,965 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2025-12-29$10.42/sh+124→ 13,089 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2025-12-29−9,876→ 23,834 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2025-12-29−124→ 2,396 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2025-12-29$41.16/sh−600→ 12,965 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2025-12-29$40.54/sh−9,400→ 13,565 total
Award
Maze Therapeutics, Inc.$MAZE
Restricted Stock Units
2025-09-22+22,000→ 22,000 total

Companies

Maze Therapeutics, Inc.
SVP, Finance
$MAZE

Recent Filings

Address

C/O MAZE THERAPEUTICS, INC. 171 OYSTER POINT BOULEVARD, SUITE 300

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov